Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse.

Abstract:

RATIONALE:Only a small percentage of individuals seeking treatment for their marijuana use achieves sustained abstinence, suggesting more treatment options are needed. OBJECTIVES:We investigated the effects of baclofen (study 1) and mirtazapine (study 2) in a human laboratory model of marijuana intoxication, withdrawal, and relapse. METHODS:In study 1, daily marijuana smokers (n = 10), averaging 9.4 (+/-3.9) marijuana cigarettes/day, were maintained on placebo and each baclofen dose (60, 90 mg/day) for 16 days. In study 2, daily marijuana smokers (n = 11), averaging 11.9 (+/-5.3) marijuana cigarettes/day, were maintained on placebo and mirtazapine (30 mg/day) for 14 days each. Medication administration began outpatient prior to each 8-day inpatient phase. On the first inpatient day of each medication condition, participants smoked active marijuana (study 1: 3.3% THC; study 2: 6.2% THC). For the next 3 days, they could self-administer placebo marijuana (abstinence phase), followed by 4 days in which they could self-administer active marijuana (relapse phase); participants paid for self-administered marijuana using study earnings. RESULTS:In study 1, during active marijuana smoking, baclofen dose-dependently decreased craving for tobacco and marijuana, but had little effect on mood during abstinence and did not decrease relapse. Baclofen also worsened cognitive performance regardless of marijuana condition. In study 2, mirtazapine improved sleep during abstinence, and robustly increased food intake, but had no effect on withdrawal symptoms and did not decrease marijuana relapse. CONCLUSIONS:Overall, this human laboratory study did not find evidence to suggest that either baclofen or mirtazapine showed promise for the potential treatment of marijuana dependence.

journal_title

Psychopharmacology

authors

Haney M,Hart CL,Vosburg SK,Comer SD,Reed SC,Cooper ZD,Foltin RW

doi

10.1007/s00213-010-1888-6

subject

Has Abstract

pub_date

2010-08-01 00:00:00

pages

233-44

issue

2

eissn

0033-3158

issn

1432-2072

journal_volume

211

pub_type

杂志文章
  • Circadian variation in behavioural responses to central 5-HT receptor stimulation in the mouse.

    abstract::The intensity of the head-twitch response and the 5-hydroxytryptamine (5-HT) syndrome (tremor, fore-paw treading, head-weaving and hind-limb abduction) was measured in male CFLP mice following IP injection of 5 mg/kg 5-methoxy-N,N-dimethyltryptamine (5-MeODMT). The results of separate experiments carried out at 1.5-h ...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00431714

    authors: Moser PC,Redfern PH

    更新日期:1985-01-01 00:00:00

  • The dorsal noradrenergic bundle and varieties of passive avoidance.

    abstract::Neither acquisition learning nor 24-h retention was significantly altered by 6-hydroxydopamine intracerebral injections which depleted forebrain noradrenaline (NA) to less than 5% of control values. The absence of passive avoidance impairment cannot be ascribed to functional recovery following the lesion (indicated by...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00427627

    authors: Mason ST,Fibiger HC

    更新日期:1979-11-01 00:00:00

  • Magnitude of change with antidepressants and placebo in antidepressant clinical trials using structured, taped and appraised rater interviews (SIGMA-RAPS) compared to trials using traditional semi-structured interviews.

    abstract:RATIONALE:Although newer interview methods such as Structured Interview Guide for the Montgomery-Asberg Depression Rating Scale (SIGMA; MADRS) with audiotaping and Rater Applied Performance Scale (RAPS) appraisal have been introduced to improve reliability of ratings in antidepressant clinical trials, there is limited ...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/s00213-014-3584-4

    authors: Khan A,Faucett J,Brown WA

    更新日期:2014-11-01 00:00:00

  • Effect of selective 5-HT1A agonists and 5-HT2 antagonists on inherited catalepsy in rats.

    abstract::The effects of the selective 5-HT1A agonists 8-OH-DPAT and flesinoxan and the selective 5-HT2 antagonists ritanserin and ketanserin on immobility time in rats bred for predisposition to catalepsy have been studied. Treatment with 8-OH-DPAT as well as flesinoxan caused a marked dose-dependent decrease in immobility tim...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/BF02245460

    authors: Kulikov AV,Kolpakov VG,Maslova GB,Kozintsev I,Popova NK

    更新日期:1994-02-01 00:00:00

  • Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys.

    abstract:RATIONALE:Gonadal steroid hormones altered opioid antinociception under some conditions in rodents, and we reported previously that chronic estradiol enhanced kappa but not mu opioid antinociception in ovariectomized rhesus monkeys. Sex differences have also been observed in the antinociceptive effects of opioid agonis...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/s002130100912

    authors: Negus SS,Mello NK

    更新日期:2002-01-01 00:00:00

  • Alterations of expression of inflammation/immune-related genes in the dorsal and ventral striatum of adult C57BL/6J mice following chronic oxycodone self-administration: a RNA sequencing study.

    abstract:INTRODUCTION:Non-medical use of prescription opioids such as the mu opioid receptor (MOP-r) agonist oxycodone is a growing problem in the USA and elsewhere. There is limited information about oxycodone's impact on diverse gene systems in the brain. OBJECTIVES:The current study was designed to examine how chronic oxyco...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/s00213-017-4657-y

    authors: Zhang Y,Liang Y,Levran O,Randesi M,Yuferov V,Zhao C,Kreek MJ

    更新日期:2017-08-01 00:00:00

  • Blockade of behavioral sensitization by MK-801: fact or artifact? A review of preclinical data.

    abstract:RATIONALE:It is widely assumed that various forms of neural and behavioral plasticity, including sensitization, are strongly dependent on the activation of N-methyl-D-aspartate (NMDA)-receptors, but evidence also exists to suggest that not all forms of sensitization are unequivocally blocked by NMDA-receptor antagonism...

    journal_title:Psychopharmacology

    pub_type: 杂志文章,评审

    doi:10.1007/s002130000395

    authors: Tzschentke TM,Schmidt WJ

    更新日期:2000-08-01 00:00:00

  • Evidence for the role of noradrenaline in some effects of quipazine.

    abstract::In mice, quipazine has shown several behavioral effects: It antagonizes hypothermia induced by a high dose of apomorphine without altering climbing or stereotyped behavior; it antagonizes oxotremorine-induced hypothermia without altering tremors or peripheral signs; and it increases the toxicity of yohimbine. These th...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00431273

    authors: Francès H,Lecrubier Y,Puech AJ,Simon P

    更新日期:1980-01-01 00:00:00

  • Individual differences in locomotor reactivity to a novel environment and sensitivity to opioid drugs in the rat. II. Agonist-induced antinociception and antagonist-induced suppression of fluid consumption.

    abstract:RATIONALE:In an animal model for vulnerability to drug abuse, rats that are more reactive to a novel environment (high responders, HRs) are more sensitive to behavioral effects of psychostimulants than are less reactive rats (low responders, LRs). In a companion article, we reported that HRs and LRs differ in sensitivi...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/s00213-004-1921-8

    authors: White DA,Kalinichev M,Holtzman SG

    更新日期:2004-12-01 00:00:00

  • Scopolamine-induced locomotor stimulation in mice: effect of diazepam and a benzodiazepine antagonist.

    abstract::The benzodiazepine diazepam and the benzodiazepine antagonist Ro 15-1788 were tested alone or in combination for their influence on scopolamine-induced locomotor stimulation in mice. The benzodiazepine antagonist had no effect by itself, but prevented the enhancement of scopolamine-induced locomotor stimulation produc...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00464583

    authors: Sansone M

    更新日期:1982-01-01 00:00:00

  • A randomized, 12-week study of the effects of extended-release paliperidone (paliperidone ER) and olanzapine on metabolic profile, weight, insulin resistance, and β-cell function in schizophrenic patients.

    abstract:OBJECTIVE:To compare matched paliperidone-ER- and olanzapine-treated schizophrenic patients on measures of glucose and lipid metabolism. METHODS:Eighty hospitalized patients with schizophrenia (DSM-IV) were randomly assigned to treatment with paliperidone ER or olanzapine for a period of 12 weeks. At baseline and ever...

    journal_title:Psychopharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s00213-013-3073-1

    authors: Hu S,Yao M,Peterson BS,Xu D,Hu J,Tang J,Fan B,Liao Z,Yuan T,Li Y,Yue W,Wei N,Zhou W,Huang M,Xu Y

    更新日期:2013-11-01 00:00:00

  • Interaction of apomorphine and haloperidol: effects on locomotion and other behaviour in the marmoset.

    abstract::The behavioural effects of increasing doses of apomorphine and haloperidol were observed in a group of six marmosets. Behaviour was classified quantitatively into categories: Locomotion, inactivity, checking (small head movements), social interaction and purposeful activities. Statistical analysis revealed that apomor...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00431987

    authors: Scraggs PR,Baker HF,Ridley RM

    更新日期:1979-01-01 00:00:00

  • Dissociable effects of the d- and l- enantiomers of govadine on the disruption of prepulse inhibition by MK-801 and apomorphine in male Long-Evans rats.

    abstract:RATIONALE:The search for novel antipsychotic drugs to treat schizophrenia is driven by the poor treatment efficacy, serious side effects, and poor patient compliance of current medications. Recently, a class of compounds known as tetrahydroprotoberberines, which includes the compound d,l-govadine, have shown promise in...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/s00213-017-4540-x

    authors: Lins BR,Marks WN,Phillips AG,Howland JG

    更新日期:2017-04-01 00:00:00

  • Lithium ions inhibit function of low- but not high-affinity muscarinic receptors of murine neuroblastoma cells (clone N1E-115).

    abstract::Murine neuroblastoma cells (clone N1E-115) possess both high- and low-affinity muscarinic receptors. The low-affinity muscarinic receptor, when stimulated, initiates the formation of cyclic GMP by activating the enzyme guanylate cyclase; whereas stimulation of the high-affinity receptor inhibits prostaglanding E1-medi...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00427901

    authors: Kanba S,Pfenning M,Richelson E

    更新日期:1985-01-01 00:00:00

  • The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys.

    abstract:RATIONALE:Salvinorin A is the active component of the hallucinogenic plant Salvia divinorum. The potential mode of action of this hallucinogen was unknown until recently. A recent in vitro study detected high affinity and efficacy of salvinorin A at kappa-opioid receptors. It was postulated that salvinorin A would prod...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/s00213-003-1638-0

    authors: Butelman ER,Harris TJ,Kreek MJ

    更新日期:2004-03-01 00:00:00

  • Atypical antipsychotics and effects on feeding: from mice to men.

    abstract:RATIONALE:So-called atypical antipsychotics (AAPs) are associated with varying levels of weight gain and associated metabolic disturbances, which in patients with serious mental illness (SMI) have been linked to non-compliance and poor functional outcomes. Mechanisms underlying AAP-induced metabolic abnormalities are o...

    journal_title:Psychopharmacology

    pub_type: 杂志文章,评审

    doi:10.1007/s00213-016-4324-8

    authors: Benarroch L,Kowalchuk C,Wilson V,Teo C,Guenette M,Chintoh A,Nesarajah Y,Taylor V,Selby P,Fletcher P,Remington GJ,Hahn MK

    更新日期:2016-07-01 00:00:00

  • Effects of buprenorphine and methadone in methadone-maintained subjects.

    abstract::Buprenorphine, a partial mu opioid agonist, is an experimental medication under development for the treatment of opioid dependence as an alternative to methadone maintenance. The present study examined the relationship between level of opioid physical dependence and response to buprenorphine administration as part of ...

    journal_title:Psychopharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF02246290

    authors: Walsh SL,June HL,Schuh KJ,Preston KL,Bigelow GE,Stitzer ML

    更新日期:1995-06-01 00:00:00

  • Differential enhancement of locomotor activity by dopamine agonists following chronic morphine treatment.

    abstract::Aniamls were administered increasing doses of morphine for 16 days. During withdrawal they were challenged with an apomorphine ester or lergotrile. These dopamine agonists produced quantitatively different effects on behaviour. The results suggest that chronic morphine administration leads to dopamine supersensitivity...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00433570

    authors: Tye NC,Horsman L,Wright FC,Pullar IA

    更新日期:1979-05-15 00:00:00

  • A comparison of diazepam stimuli in aged and adult rats.

    abstract::Young adult rats (5 months) were compared with aged (28 months) rats in their ability to learn and perform in a diazepam drug discrimination. Both groups of rats were drug naive at the onset of the experiment. Adult and aged animals learned to discriminate diazepam. In general, the response rates under both drug and v...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00187245

    authors: Amrick CL,Bennett DA

    更新日期:1987-01-01 00:00:00

  • Evidence for a role of D1 dopamine receptors in d-amphetamine's effect on timing behaviour in the free-operant psychophysical procedure.

    abstract:RATIONALE:Temporal differentiation of operant behaviour is sensitive to dopaminergic manipulations. Studies using the fixed-interval peak procedure implicated D2 dopamine receptors in these effects. Less is known about the effects of dopaminergic manipulations on temporal differentiation in other timing schedules. OBJ...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/s00213-006-0339-x

    authors: Cheung TH,Bezzina G,Asgari K,Body S,Fone KC,Bradshaw CM,Szabadi E

    更新日期:2006-04-01 00:00:00

  • [11C]Ro 15-4513, a ligand for visualization of benzodiazepine receptor binding. Preparation, autoradiography and positron emission tomography.

    abstract::Ro 15-4513, a partial inverse agonist at the benzodiazepine (BZ) receptor site was labelled with 11C and used for in vitro autoradiography on human post mortem brain sections and for positron emission tomography (PET) on Cynomolgus monkeys. The total radiochemical yield of [11C]Ro 15-4513 was 30-40% with an overall sy...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/BF02245279

    authors: Halldin C,Farde L,Litton JE,Hall H,Sedvall G

    更新日期:1992-01-01 00:00:00

  • Prolonged antidopaminergic actions of single doses of butyrophenones in the rat.

    abstract::Rats were treated once with doses of haloperidol or of droperidol below and above the acute ID50 vs the dopamine agonist apomorphine; they were later challenged with an acute dose of apomorphine (0.3 mg/kg, SC) and rated for stereotyped behavioral responses. The two neuroleptics were similar in acute anti-apomorphine ...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00431801

    authors: Campbell A,Baldessarini RJ,Teicher MH,Kula NS

    更新日期:1985-01-01 00:00:00

  • Fluvoxamine dose-dependent interaction with haloperidol and the effects on negative symptoms in schizophrenia.

    abstract::Augmentation with low-dose fluvoxamine (50-100 mg/day) to antipsychotic treatment may improve the negative symptoms in schizophrenic patients, but involves a risk of drug-drug interaction. We studied the effects of fluvoxamine on plasma concentrations of haloperidol and reduced haloperidol, and their clinical symptoms...

    journal_title:Psychopharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00213-003-1567-y

    authors: Yasui-Furukori N,Kondo T,Mihara K,Inoue Y,Kaneko S

    更新日期:2004-01-01 00:00:00

  • Neurochemical correlates of relapse to d-amphetamine self-administration by rats induced by stimulation of the ventral subiculum.

    abstract:RATIONALE AND OBJECTIVES:Previous studies show that electrical stimulation of the ventral subiculum (vSub) can reinstate drug-seeking behavior in rats following extinction. This study examined whether vSub stimulation could also evoke reinitiation of d-amphetamine (d-AMPH) self-administration during voluntary abstinenc...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/s00213-002-1337-2

    authors: Taepavarapruk P,Phillips AG

    更新日期:2003-07-01 00:00:00

  • Cognitive effects of lithium treatment in normal volunteers.

    abstract::Patients taking lithium often report difficulties in concentration, memory, learning, and attention and many of these complaints are verified on psychometric testing. Laboratory tests of cognitive functions in healthy volunteers on chronic lithium demonstrate that disruptions in memory-learning processes are apparent ...

    journal_title:Psychopharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00427911

    authors: Weingartner H,Rudorfer MV,Linnoila M

    更新日期:1985-01-01 00:00:00

  • The effects of exercise on cigarette cravings and brain activation in response to smoking-related images.

    abstract:RATIONALE:Smokers show heightened activation toward smoking-related stimuli and experience increased cravings which can precipitate smoking cessation relapse. Exercise can be effective for modulating cigarette cravings and attenuating reactivity to smoking cues, but the mechanism by which these effects occur remains un...

    journal_title:Psychopharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s00213-011-2610-z

    authors: Janse Van Rensburg K,Taylor A,Benattayallah A,Hodgson T

    更新日期:2012-06-01 00:00:00

  • Differential development of behavioral tolerance and the subsequent hedonic effects of alcohol in AA and ANA rats.

    abstract:RATIONALE:There at least two ways in which tolerance development to alcohol's behavioral effects could interact with its subsequent intake: 1) tolerance to alcohol's reward or reinforcing effects per se could lead to increased consumption, and 2) tolerance to alcohol's aversive effects could unmask alcohol's rewarding ...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/s002130000477

    authors: Gauvin DV,Baird TJ,Briscoe RJ

    更新日期:2000-09-01 00:00:00

  • Responsiveness to cocaine challenge in adult rats following prenatal exposure to cocaine.

    abstract::Adult rats that were gestationally exposed to cocaine and control offspring were examined for their sensitivity to challenge doses of cocaine. Offspring were derived from Sprague-Dawley dams that had received subcutaneous injections of 40 mg/kg per 3 cc cocaine hydrochloride daily on gestational days 8-20, pair-fed da...

    journal_title:Psychopharmacology

    pub_type: 杂志文章

    doi:10.1007/BF02244870

    authors: Heyser CJ,Rajachandran L,Spear NE,Spear LP

    更新日期:1994-09-01 00:00:00

  • Correction to: Chronic phencyclidine treatment impairs spatial working memory in rhesus monkeys.

    abstract::After publication of this paper, the authors determined an error in Fig. 2C. ...

    journal_title:Psychopharmacology

    pub_type: 已发布勘误

    doi:10.1007/s00213-019-05269-1

    authors: Zhang B,Xiong F,Ma Y,Li B,Mao Y,Zhou Z,Yu H,Li J,Li C,Fu J,Wang J,Zhao X

    更新日期:2019-07-01 00:00:00

  • A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor.

    abstract:RATIONALE:Schizophrenia is a complex neuropsychiatric disorder characterized, in part, by impaired dopamine signaling. TAK-063 is a selective inhibitor of phosphodiesterase 10A, a key regulator of intracellular signaling pathways that is highly expressed in the striatum. OBJECTIVE:Safety, tolerability, and pharmacokin...

    journal_title:Psychopharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s00213-016-4412-9

    authors: Tsai M,Chrones L,Xie J,Gevorkyan H,Macek TA

    更新日期:2016-10-01 00:00:00